These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18861403)

  • 1. The neutralization of the mouse-adapted poliomyelitis virus by the sera of patients, family contacts, and normal children in Los Angeles.
    PAIT CF; KESSEL JF; GROSSMAN P
    Am J Hyg; 1948 May; 47(3):335-44. PubMed ID: 18861403
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible occurrence of multiple antigens in type 2 poliomyelitis and GDVII mouse encephalomyelitis viruses.
    RUSTIGIAN R; HAVENS P; KOLNER M
    Proc Soc Exp Biol Med; 1954 Jul; 86(3):500-4. PubMed ID: 13194703
    [No Abstract]   [Full Text] [Related]  

  • 3. Reverse interference between simian and murine poliomyelitis virus in guinea pigs.
    JUNGEBLUT CW
    Proc Soc Exp Biol Med; 1948; 68(3):615-7. PubMed ID: 18884309
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of phenosulfazole to influence the course of infection with murine poliomyelitis virus in mice.
    JUNGEBLUT CW
    Proc Soc Exp Biol Med; 1949 Feb; 70(2):371-3. PubMed ID: 18112811
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relation between theiler neurotropic viruses, foot and mouth disease and Lansing polio].
    LEVADITI C; VAISMAN A
    C R Seances Soc Biol Fil; 1945 Oct; 139():875. PubMed ID: 21026173
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the effect of some acridine derivatives on poliomyelitis and murine encephalomyelitis viruses].
    BYCHKOVSKAIA OV; BAZHEDOMOVA MA; BABINA NS; BOGDANOV GF; SEMENOVA NS
    Vopr Virusol; 1961; 6():736-8. PubMed ID: 13875284
    [No Abstract]   [Full Text] [Related]  

  • 7. The neutralization of the mouse-adapted poliomyelitis virus by the sera of children.
    PAIT CF; KESSEL JR; GROSSMAN P
    J Bacteriol; 1946 May; 51():614. PubMed ID: 20987054
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic classification of poliomyelitis viruses. III. Results obtained with the method of neutralization with prototype sera. C. Studies from the University of Kansas on twenty-five strains.
    WENNER HA; RABE EF
    Am J Hyg; 1951 Sep; 54(2):243-54. PubMed ID: 14877804
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic classification of poliomyelitis viruses. III. Results obtained with the method of neutralization with prototype sera. D. Studies from the University of Southern California on sixteen strains.
    KESSELL JF; PAIT CF; KOKKO UP
    Am J Hyg; 1951 Sep; 54(2):251-4. PubMed ID: 14877805
    [No Abstract]   [Full Text] [Related]  

  • 10. [Provocation of an infection by vaccination. Part V. Provocation after experimental infection with mouse-adapted poliomyelitis virus].
    RAETTIG H; GODGLUECK G
    Zentralbl Bakteriol; 1960 May; 179():93-112. PubMed ID: 13854444
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutralization test of animal sera collected in Japan against poliomyelitis virus Lansing strain.
    KITAOKA M; MIURA T
    Jpn J Med; 1951 Oct; 4(5):297-305. PubMed ID: 14927265
    [No Abstract]   [Full Text] [Related]  

  • 12. The neutralization of the mouse-adapted Lansing strain of poliomyelitis virus by the serum of patients and contacts.
    BROWN GC; FRANCIS T
    J Immunol; 1947 Sep; 57(1):1-10. PubMed ID: 20264681
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of oxidation and reduction on the infectivity of poliomyelitis virus.
    LUND E; LYCKE E
    Arch Gesamte Virusforsch; 1961; 11():100-10. PubMed ID: 13764266
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemagglutination of strains of murine poliomyelitis virus].
    HALLAUER C
    Arch Gesamte Virusforsch; 1951 Mar; 4(3):224-48. PubMed ID: 14830178
    [No Abstract]   [Full Text] [Related]  

  • 15. Infection and immunity in offspring of mice inoculated during gestation with murine poliomyelitis virus.
    KNOX AW
    Proc Soc Exp Biol Med; 1950 Aug; 74(4):792-6. PubMed ID: 14781185
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of antibody in experimental poliomyelitis; reproducibility of endpoint in a mouse neutralization test with Lansing poliomyelitis virus.
    MORGAN IM
    Am J Hyg; 1947 May; 45(3):372-8. PubMed ID: 20240022
    [No Abstract]   [Full Text] [Related]  

  • 17. Monkey pathogenicity of various strains of murine poliomyelitis virus; experiments with Col. SK-MM group.
    JUNGEBLUT CW
    Proc Soc Exp Biol Med; 1949 Dec; 72(3):534-9, illust. PubMed ID: 15400788
    [No Abstract]   [Full Text] [Related]  

  • 18. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES.
    DEIBEL R; MACDONALD D
    N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893
    [No Abstract]   [Full Text] [Related]  

  • 19. Active and inactive murine poliomyelitis virus as interfering agents against poliomyelitic infection in monkeys.
    JUNGEBLUT CW
    Proc Soc Exp Biol Med; 1948 May; 68(1):19-22. PubMed ID: 18863663
    [No Abstract]   [Full Text] [Related]  

  • 20. Monkey pathogenicity of various strains of murine poliomyelitis virus; experiments with Lansing, MEF, and Yale-SK group.
    JUNGEBLUT CW
    Proc Soc Exp Biol Med; 1949 Dec; 72(3):532-4. PubMed ID: 15400787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.